Boston, MA – March 23: Wendy Wakeman, a MassGOP member and strategist serving as spokesperson for the Coalition for a Healthy Massachusetts, a group behind a ballot initiative that would end recreational marijuana sales. She speaks at a public hearing held at the Massachusetts State House on March 23, 2026. (Photo by David L. Ryan/The Boston Globe via Getty Images)
On November 3, Massachusetts voters will decide Question 8, a ballot measure that would repeal the state’s licensed adult-use cannabis market. If it passes, the vote would mark the first time voters anywhere have rolled back an existing state cannabis legalization law — and it would test something the industry has spent nearly a decade building: banking relationships inside a market that operates entirely outside federal law.
For the banks, credit unions and specialty lenders financing Massachusetts’ cannabis industry, what happens on Election Day matters less than what happens the moment it’s decided. Some may and, perhaps, should already be modeling their exposure.
Fast facts
Question 8 would repeal Chapters 94G and 64N of Massachusetts law, ending licensed adult-use retail sales, cultivation licensing, home cultivation rights and the state’s marijuana excise tax
Medical cannabis and simple possession (up to two ounces, with a civil penalty above one ounce) would remain legal
If voters approve it, the repeal takes effect January 1, 2028
Massachusetts’ regulated adult-use market has generated more than $9 billion in gross sales since retail sales began in 2018, according to state cannabis regulators; industry estimates put cumulative state and local tax revenue at roughly $1.8 billion
Recent statewide polling shows a majority of voters opposed to repeal, though the race isn’t settled and roughly one in ten voters remain undecided
What Question 8 Would Actually Do
Formally titled “An Act to Restore a Sensible Marijuana Policy,” Question 8 would not recriminalize cannabis in Massachusetts. Adults 21 and older could still possess up to an ounce without penalty, and up to two ounces with a civil fine. The state’s medical cannabis program, which operates under separate statutes, would continue unchanged.
What the measure would do is repeal the two laws — Chapters 94G and 64N — that license, regulate and tax the commercial adult-use market Massachusetts voters created in 2016. Retail sales, cultivation licenses and the home-cultivation rights tied to that statute would all disappear. The state’s Cannabis Control Commission currently oversees more than 230 licensed dispensaries, roughly 150 cultivation operations and close to 90 product manufacturers; under Question 8, those businesses would need to convert to medical-only licenses, sell off inventory or close.
Opponents, organized under the banner Stop the Repeal, argue the measure would erase jobs and tax revenue built over a decade — and recent polling favors their position. A University of Massachusetts Amherst survey released in late August found 55% of voters opposed and 33% in favor, making Question 8 the least popular of nine measures on this year’s ballot. An earlier Suffolk University poll in March showed a tighter race: 38% supporting repeal, 52% opposed, and roughly 10% undecided.
A Market Built Over Eight Years
Adam Stettner, CEO of cannabis lender Fundcanna, has watched Massachusetts grow from one of the country’s earliest adult-use markets into one of its largest. Whatever voters decide, he argues over email that the economics of dismantling a functioning regulated market are hard to justify.
“Massachusetts has moved more than $9 billion in cannabis sales through a tested, tracked and age-gated regulated marketplace, generated roughly $1.8 billion in state and local tax revenue, and has evidence that consumers have migrated away from illicit sources,” Stettner said. “Rolling that system back doesn’t eliminate the demand or use of cannabis. It pushes consumers back toward an illicit market where there is no meaningful product testing, tracking or age verification — and where the state collects no tax revenue.”
To Stettner, repeal would reverse years of policy work, not just close some stores. “We’ve spent years building regulated markets designed to bring an existing industry into safety and compliance, creating greater accountability and consumer safety,” he said. “It would be difficult to understand Massachusetts moving in the opposite direction at a time when much of the country — even the federal government — is considering how cannabis policy should evolve rather than retreat.”
He’s pointing to a federal landscape that has shifted in 2026. In April, the Justice Department moved medical marijuana from Schedule I to Schedule III of the Controlled Substances Act. In June, bipartisan lawmakers reintroduced the SAFE Banking Act, again aiming to give financial institutions clearer legal footing to serve state-licensed cannabis businesses. Adult-use cannabis remains fully illegal under federal law regardless — a gap that sits at the center of the banking question Massachusetts is now forcing.
Why Banks Won’t Wait For The Election Results
Cannabis businesses already operate with one foot outside the banking system. Federally chartered banks generally won’t touch them, leaving state-chartered banks and credit unions to fill the gap under Bank Secrecy Act compliance programs that demand constant monitoring and reporting. Joseph Silvia, a former Federal Reserve lawyer who now advises financial institutions on cannabis banking at Duane Morris, says a successful repeal would move quickly from ballot question to balance sheet.
If the repeal effort succeeds, Silvia said via email, “Massachusetts state-chartered banks serving cannabis customers would likely shut down those banking services and customer accounts in line with whatever time frame is provided for by the repeal.” He added that he’d expect the same institutions to “very seriously consider shutting down similar operations outside Massachusetts and exit that line of business entirely” — meaning a single state’s policy reversal could ripple into cannabis banking programs in states with no repeal effort of their own.
The Mechanics: How A Repeal Would Hit Accounts And Loans
Steven Schain, who chairs the cannabis practice at Malkin Law and has spent years building bank depository and lending programs for the industry, has mapped out what he expects to happen mechanically if Question 8 passes — and argues the law’s built-in transition window won’t matter much in practice.
Under the Bank Secrecy Act, accepting deposits tied to marijuana sales is treated as handling proceeds of federally illegal activity. Question 8 includes a roughly 14-month “off-ramp” before the repeal takes effect on January 1, 2028, but Schain says via email most banks won’t wait that long. Standard banking agreements typically require a business to remain “otherwise in compliance with applicable state and federal laws” — language he says gives even risk-tolerant banks grounds to act the moment the repeal passes, not on its effective date.
His outline of what follows:
Deposit accounts close fast. Banks stop processing deposits and withdrawals, notify the business its account is closed, and issue a certified check for the balance.
Cash access disappears immediately. Because few operators maintain separate medical and adult-use accounts, an entire business can lose banking access at once — unable to deposit cash receipts, run payroll, pay vendors or taxes, or process debit transactions.
Even the certified check becomes hard to deposit. Once the underlying activity is treated as illegal, Schain says businesses can struggle to deposit the certified check representing their own former account balance.
Loans get called. Because loans typically can’t be neatly split between medical and adult-use collateral, lenders may call the full unpaid balance — principal and interest — due immediately, putting the borrower in default.
Most cannabis businesses, Schain says, can’t produce that much capital on short notice. Many loans are secured by real estate and personal guarantees from company principals, which is why he expects the mechanics of a repeal — not just the politics of it — to “crash most Massachusetts” marijuana-related businesses.
How Lenders Are Already Pricing In The Risk
For Fundcanna and similar specialty lenders, the Massachusetts vote is a live test of something they underwrite for constantly: the possibility that the regulatory ground shifts under a loan that’s still outstanding.
“The Massachusetts situation is an example of why awareness of regulatory risk must be part of the original funding decision in cannabis,” Stettner said. “We don’t evaluate a company based solely on existing regulation. We must consider how those rules could change while our capital is outstanding, for better or worse.”
That framework shapes how Fundcanna says it would respond if voters approve the repeal. Rather than exiting the state outright, Stettner described a client-by-client approach. “We wouldn’t automatically terminate every existing funding relationship or immediately stop doing business in the state,” he said. “Rather, we would evaluate each client individually based on their exposure to adult-use sales, whether they could continue operating legally under the remaining regulatory structure, their liquidity and their ability to meet their obligations.”
New clients face a different calculus. “For new clients, increasing regulatory uncertainty would factor into our underwriting and appetite for additional exposure,” Stettner said. “That could mean being more selective, reducing exposure or ultimately pausing new funding if we believed the risk warranted it.” The goal, he added, isn’t to react to headlines: “As a capital provider, we seek to manage risk and maximize repayment, not react to a headline or regulatory development. The important thing is understanding the risk before the rules change and managing exposure accordingly.”
The Bigger Picture
Whatever Massachusetts voters decide on November 3, the vote has already become a reference point for how banks, credit unions, and lenders weigh cannabis policy risk elsewhere. It’s the first time an existing state adult-use law has faced a repeal vote — and both the banking mechanics described and the underwriting responses outlined here are likely to shape how financial institutions treat regulatory risk in every other cannabis market, not just Massachusetts.
The ballot box will settle the politics in November. Inside bank compliance departments and risk committees, the risk modeling has already started.
This article was originally published on Forbes.com
